Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung

Bradley J Undem, Elliot C. Dick, Carl K. Buckner

Research output: Contribution to journalArticle

Abstract

Vasoactive intestinal peptide (VIP) was found to inhibit ovalbumin-induced histamine release from guinea-pig minced lung. Maximum inhibition occured with a 10-20 min time of preincubation with VIP. Spontaneous histamine release was not altered by VIP. With 2 × 10-6 M VIP, the dose-response curve to ovalbumin was shifted about 3-fold to the right, but the maximum histamine release was unaltered. Respiratory tract infection with parainfluenza 3 virus did not influence the inhibitory effect of VIP on histamine release.

Original languageEnglish (US)
Pages (from-to)247-250
Number of pages4
JournalEuropean Journal of Pharmacology
Volume88
Issue number2-3
DOIs
StatePublished - Mar 25 1983
Externally publishedYes

Fingerprint

Histamine Release
Vasoactive Intestinal Peptide
Guinea Pigs
Antigens
Lung
Ovalbumin
Paramyxoviridae Infections
Respiratory Tract Infections
Viruses

Keywords

  • Guinea-pig lung
  • Histamine release
  • Parainfluenza 3 injection
  • Vasoactive intestinal peptide

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung. / Undem, Bradley J; Dick, Elliot C.; Buckner, Carl K.

In: European Journal of Pharmacology, Vol. 88, No. 2-3, 25.03.1983, p. 247-250.

Research output: Contribution to journalArticle

@article{8276bcc43dc84ab7a053525c0f434ad6,
title = "Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung",
abstract = "Vasoactive intestinal peptide (VIP) was found to inhibit ovalbumin-induced histamine release from guinea-pig minced lung. Maximum inhibition occured with a 10-20 min time of preincubation with VIP. Spontaneous histamine release was not altered by VIP. With 2 × 10-6 M VIP, the dose-response curve to ovalbumin was shifted about 3-fold to the right, but the maximum histamine release was unaltered. Respiratory tract infection with parainfluenza 3 virus did not influence the inhibitory effect of VIP on histamine release.",
keywords = "Guinea-pig lung, Histamine release, Parainfluenza 3 injection, Vasoactive intestinal peptide",
author = "Undem, {Bradley J} and Dick, {Elliot C.} and Buckner, {Carl K.}",
year = "1983",
month = "3",
day = "25",
doi = "10.1016/0014-2999(83)90012-2",
language = "English (US)",
volume = "88",
pages = "247--250",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Inhibition by vasoactive intestinal peptide of antigen-induced histamine release from guinea-pig minced lung

AU - Undem, Bradley J

AU - Dick, Elliot C.

AU - Buckner, Carl K.

PY - 1983/3/25

Y1 - 1983/3/25

N2 - Vasoactive intestinal peptide (VIP) was found to inhibit ovalbumin-induced histamine release from guinea-pig minced lung. Maximum inhibition occured with a 10-20 min time of preincubation with VIP. Spontaneous histamine release was not altered by VIP. With 2 × 10-6 M VIP, the dose-response curve to ovalbumin was shifted about 3-fold to the right, but the maximum histamine release was unaltered. Respiratory tract infection with parainfluenza 3 virus did not influence the inhibitory effect of VIP on histamine release.

AB - Vasoactive intestinal peptide (VIP) was found to inhibit ovalbumin-induced histamine release from guinea-pig minced lung. Maximum inhibition occured with a 10-20 min time of preincubation with VIP. Spontaneous histamine release was not altered by VIP. With 2 × 10-6 M VIP, the dose-response curve to ovalbumin was shifted about 3-fold to the right, but the maximum histamine release was unaltered. Respiratory tract infection with parainfluenza 3 virus did not influence the inhibitory effect of VIP on histamine release.

KW - Guinea-pig lung

KW - Histamine release

KW - Parainfluenza 3 injection

KW - Vasoactive intestinal peptide

UR - http://www.scopus.com/inward/record.url?scp=0020621379&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020621379&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(83)90012-2

DO - 10.1016/0014-2999(83)90012-2

M3 - Article

C2 - 6189733

AN - SCOPUS:0020621379

VL - 88

SP - 247

EP - 250

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -